Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes.
暂无分享,去创建一个
Y. Shentu | B. Goldstein | V. Fonseca | B. Staels | G. Golm | K. Kaufman | A. Johnson‐Levonas | J. Morgan | H. Steinberg | Shentu Yue